| Literature DB >> 31211215 |
Anshu Gupta1, Tanima Dwivedi2.
Abstract
INTRODUCTION: The initial examination of cerebrospinal fluid (CSF) for proteins, glucose, and leukocytes, is still the gold standard investigation in some neurological conditions like meningitis. Aims and objective of the present study were to determine the accuracy of urinary reagent strip for semi-quantitative analysis of protein, glucose, leucocytes and erythrocytes in CSF along with its role in emergency for rapid diagnosis of neurological conditions.Entities:
Keywords: Accuracy; Cerebrospinal fluid analysis; Emergency setting; Semi-quantitative; Urinary reagent strips
Year: 2019 PMID: 31211215 PMCID: PMC6562142 DOI: 10.1016/j.plabm.2019.e00124
Source DB: PubMed Journal: Pract Lab Med ISSN: 2352-5517
Fig. 1Showing color chart scale as shown on the label of combur-10urinary reagent strip.
Reference standard for all the parameters as shown in strip label of combur-10urinary reagent strip.
| Parameter | Normal value in CSF | Principle of strip test | No color | 1+ | 2+ | 3+ | 4+ |
|---|---|---|---|---|---|---|---|
| CSF Leucocyte (cells/mm3) | <5 | Leucocyte esterase estimation | <10 | 10–75 | 75–499 | >500 | – |
| CSF Protein (mg/dl) | 15–45 | Protein error of pH indicator | <29 | 30–99 | 100–499 | >500 | – |
| CSF Glucose (mg/dl) | 40–70 | glucose oxidase-peroxidase method | <50 | 50–99 | 100–299 | 300–999 | 1000 |
| CSF Eythrocyte (cells/cumm) | Absent | Peroxidase method | <5 | 5–10 | 25 | 50 | 250 |
Fig. 2Box & whisker plot showing the distribution of reference standard values for each strip color, (a) leucocytes, (b) proteins, (c) glucose and (d) erythrocyte. Horizontal line, box, whisker and dots indicate median (50th centile), 25th and 75th centile, ranges and outliers respectively.
Diagnostic accuracy of urinary reagent strip test when compared with reference standard values of parameters.
| CSF LEUCOCYTE (95% CI) | CSF PROTEIN (95% CI) | CSF GLUCOSE (95% CI) | CSF ERYTHROCYTE (95% CI) | |
|---|---|---|---|---|
| True Positive | 117 | 285 | 315 | 99 |
| False Positive | 09 | 33 | 03 | 00 |
| False Negative | 00 | 03 | 06 | 00 |
| True Negative | 234 | 39 | 36 | 261 |
| Sensitivity | 100% (90.9%–100%) | 98.9% (94.3%–99.9%) | 98.1% (93.4%–99.8%) | 100% (89.4%–100%) |
| Specificity | 96.3% (89.6%–99.2%) | 54.2% (32.8%–74.5%) | 92.3% (63.9%–99.8%) | 100% (95.9%–100%) |
| Positive Likelihood Ratio | 27 (8.9–81.9) | 2.2 (1.4–3.34) | 12.8 (1.9–83.8) | 00 |
| Negative Likelihood Ratio | 00 | 0.02 (0.00–0.14) | 0.02 (0.01–0.08) | 00 |
| Disease prevalence | 32.5% (24.2%–41.6%) | 80% (71.72%–86.75%) | 89.2% (82.2%–94.1%) | 27.5% (19.8 %–36.4%) |
| Positive Predictive Value (PPV) | 92.9% (80.5%–98.5%) | 89.6% (82.19%–94.70%) | 99.1% (94.9%–99.9%) | 100% (89.4%–100%) |
| Negative Predictive Value (NPV) | 100% (95.38%–100.00%) | 92.9% (66.13%–99.82%) | 85.7% (57.2%–98.2%) | 100% (95.9%–100%) |
| Area under the ROC curve (AUC) | 0.92 | 0.714 | 0.887 | 1.000 |
| Standard Error | 0.028 | 0.0705 | 0.0828 | 0.000 |
Fig. 3Receiver operator curves (ROC curve)for performance of reagent strips along with area under the curve (AUC), (a) leucocytes, (b) proteins, and (c) glucose and (d) erythrocytes.
Interpretation of CSF samples.
| Appearance | Glucose (mg/dl) | Protein (mg/dl) | Leucocyte (cells/mm3) | Type of Leucocyte | |
|---|---|---|---|---|---|
| Normal | Clear | 40–70 | 15–45 | 0–8 | CSF lymphonuclearcytosis |
| Bacterial meningitis | Turbid | <40 | 100–500 | ≥500 | CSF polymorphonuclearcytosis |
| Tuberculosis meningitis | Slightly opaque, cobweb formation | <40 | 50–300 | 100–600 | CSF lymphonuclearcytosis or Mixed |
| Aseptic meningitis | Clear | Normal | Normal to Mild increased | 5–300 | CSF lymphonuclearcytosis |
| Guillain–Barré syndrome | Clear | Normal | 100–500 | 0–8 | CSF lymphonuclearcytosis |
Fig. 4Spectrum of neurological disorders studied.
Comparison between definitive test and strip tests.
| CSF Leucocyte | No: | Minimum | 1st quartile | Median | 3rd quartile | Maximum | Interquartile Range | No: of Outliers |
|---|---|---|---|---|---|---|---|---|
| 0 (0–9/cumm) | 270 | 0 | 0 | 0 | 5 | 150 | 05 | 17 |
| 1 (10–25/cumm) | 42 | 8 | 15 | 28 | 53 | 80 | 38 | 00 |
| 2 (25–75/cumm) | 21 | 40 | 50 | 60 | 75 | 80 | 25 | 00 |
| 3 (≥500/cumm) | 27 | 100 | 208 | 500 | 610 | 1500 | 403 | 01 |
| 0 (0–29 mg/dl) | 72 | 15 | 19 | 28 | 47 | 119 | 29 | 02 |
| 1 (30–99 mg/dL) | 153 | 16 | 34 | 45 | 73 | 344 | 39 | 03 |
| 2 (100–499 mg/dL) | 96 | 41 | 60 | 93 | 138 | 371 | 78 | 03 |
| 3 (>500 mg/dL) | 39 | 93 | 160 | 286 | 347 | 550 | 187 | 00 |
| 0 (0–49 mg/dL) | 33 | 10 | 12 | 20 | 27 | 120 | 15 | 02 |
| 1 (50–99 mg/dL) | 147 | 15 | 45 | 55 | 61 | 76 | 16 | 02 |
| 2 (100–299 mg/dL) | 153 | 35 | 58 | 65 | 75 | 125 | 17 | 03 |
| 3 (300–999 mg/dL) | 27 | 14 | 88.5 | 138 | 222 | 450 | 133 | 01 |
| 4 (>1000 mg/dL) | 00 | 00 | 00 | 00 | 00 | 00 | 00 | 00 |
| 0 (0–4/cumm) | 264 | 00 | 00 | 00 | 00 | 05 | 00 | 18 |
| 1 (5–10/cumm) | 30 | 10 | 10 | 18.5 | 25 | 30 | 15 | 00 |
| 2 (11–25/cumm) | 06 | 34 | 34 | 44.5 | 55 | 55 | 21 | 00 |
| 3 (26–50/cumm) | 21 | 50 | 100 | 175 | 184 | 188 | 84 | 00 |
| 4 (>250/cumm) | 39 | 250 | 250 | 350 | 490 | 1800 | 240 | 00 |
Comparison between our study and various other studies.
| Our study | Chikkannaiah e | Joshi et al. (2013) | Parmar et al. (2004) | Romanelli et al. (2001) | Maclennan et al. (2004) | |
|---|---|---|---|---|---|---|
| Reference No: | – | 2 | 6 | 3 | 7 | 9 |
| Cases | 360 | 103 | 75 | 63 | 154 | 200 |
| Leucocytes ≥10 cells/cumm | Sensitivity: 100.0% | Sensitivity: 97% | Sensitivity: 85% | Sensitivity: 97%, | Sensitivity: 91% | NOT DONE |
| CSF Protein | Sensitivity: 99% | NOT DONE | ||||
| CSF Glucose | Sensitivity: 98% | NOT DONE | ||||
| CSF Erythrocyte | Sensitivity: 100% | NOT DONE | NOT DONE | NOT DONE | NOT DONE | NOT DONE |
| Spectrum of cases | Meningitis Tuberculous: 200 Bacterial: 80 Aseptic: 30 Subacute Sclerosing Panencephalitis (SSPE):03 Guillain–Barré syndrome (GBS): 06 CNS Tumor: 01 Normal Finding: 40 | Meningitis | In bacterial meningitis, nitrate patch will become positive because of increased granulocytes. |